Norfloxacin for prevention of bacterial infections in granulocytopenic patients

The American Journal of Medicine

Volumn 82, Issue 6 SUPPL. 2, 1987, Pages 40-46

  Winston, Drew J ^a   Ho, Winston G ^a   Champlin, Richard E ^a   Karp, Judith ^a   Bartlett, John ^a   Finley, Rebecca S ^a   Joshi, Jai H ^a   Talbot, George ^a   Levitt, Lee ^a   Deresinski, Stan ^a   Corrado, Michael ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; NORFLOXACIN; POLYMYXIN; SULFAMETHOXAZOLE; TRIMETHOPRIM; VANCOMYCIN;

ADULT; BACTEREMIA; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; GRANULOCYTOPENIA; HUMAN; INFECTION PREVENTION; MALE; ORAL DRUG ADMINISTRATION;

ADOLESCENT; ADULT; AGED; AGRANULOCYTOSIS; BACTERIAL INFECTIONS; COMPARATIVE STUDY; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; HUMAN; MIDDLE AGE; MYCOSES; NORFLOXACIN; POLYMYXIN; RANDOM ALLOCATION; SEPTICEMIA; SULFAMETHOXAZOLE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRIMETHOPRIM; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; VANCOMYCIN;

EID: 0023633996     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(87)90617-6     Document Type: Article

References (27)

1. Infections in the compromised host
2. Origin of infection in acute nonlymphocytic leukemia: significance of hospital acquisition of potential pathogens
3. Infection prevention in acute nonlymphocytic leukemia: laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis
4. A prospective controlled investigation of prophylactic trimethoprim-sulfamethoxazole in hospitalized granulocytopenic patients
5. A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia
6. Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukemia
7. Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid
8. Double-blind randomized study of prophylactic trimethoprim-sulfamethoxazole in granulocytopenic patients with hematologic malignancies
9. Colonization resistance of the digestive tract of mice during systemic antibiotic treatment
10. Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract
11. Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia
12. In vitro activity of norfloxacin, a quinolonecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim
13. Effect of inoculum size on in vitro activity of norfloxacin against fecal anaerobic bacteria: rationale for selective decontamination of the digestive tract
14. Recovery of norfloxacin in feces after administration of a single oral dose to human volunteers
15. Selective decontamination by norfloxacin: a study of 10 human volunteers (abstr 137)
16. Antibacterial activity of norfloxacin in the gastrointestinal tract of rats
17. Norfloxacin inhibits bacterial growth by antagonism of DNA gyrase and inhibits conjugal plasmid transfer (abstr 1021)
18. Piperacillin plus amikacin therapy vs. carbenicillin plus amikacin therapy in febrile granulocytopenic patients
19. Selective suppression of alimentary tract microbial flora as prophylaxis during granulocytopenia
20. Neutropenia, fever, and infection
21. Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia
22. Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy
23. Septicemia caused by Viridans streptococci in neutropenic patients with leukemia
24. Significant Viridans streptococcal infection in children with cancer (abstr 803)
25. Antimicrobial agents
26. Chemoprophylaxis of bacterial infections in granulocytopenic patients